Core Financial Statements From 2010 to 2026

CORZ Stock  USD 16.83  0.00  0.00%   
Core Scientific's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Core Scientific's valuation are provided below:
Gross Profit
34.1 M
Profit Margin
(2.30)
Market Capitalization
B
Enterprise Value Revenue
16.9539
Revenue
334.2 M
We have found one hundred twenty available fundamental signals for Core Scientific Common, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Core Scientific Common prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.

Core Scientific Total Revenue

424.91 Million

Check Core Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Core Scientific's main balance sheet or income statement drivers, such as Depreciation And Amortization of 145 M, Interest Expense of 49.3 M or Selling General Administrative of 95.4 M, as well as many indicators such as Price To Sales Ratio of 6.65, Dividend Yield of 0.0 or Days Sales Outstanding of 0.8. Core financial statements analysis is a perfect complement when working with Core Scientific Valuation or Volatility modules.
  
Build AI portfolio with Core Stock
Check out the analysis of Core Scientific Correlation against competitors.

Core Scientific Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.1 B1.8 B692.3 M
Slightly volatile
Short and Long Term Debt Total1.4 B1.4 B463.9 M
Slightly volatile
Other Current Liabilities66.3 M79.6 M38.5 M
Slightly volatile
Total Current Liabilities223.5 M154.7 M111 M
Slightly volatile
Property Plant And Equipment Net502.7 M771.4 M314 M
Slightly volatile
Net Debt354.3 M418.1 M180.9 M
Slightly volatile
Accounts Payable21 M22.2 M21.9 M
Slightly volatile
CashB961.6 M229.2 M
Slightly volatile
Non Current Assets Total737.1 M799.1 M438.8 M
Slightly volatile
Non Currrent Assets Other15.3 M27.6 M12.4 M
Slightly volatile
Other Assets70.6 M79.4 M86.7 M
Slightly volatile
Long Term Debt1.3 B1.2 B396.4 M
Slightly volatile
Cash And Short Term InvestmentsB961.6 M231.2 M
Slightly volatile
Net Receivables2.1 M1.2 M1.1 M
Slightly volatile
Common Stock Shares Outstanding243.9 M294.2 M145.3 M
Slightly volatile
Liabilities And Stockholders Equity1.1 B1.8 B689 M
Slightly volatile
Non Current Liabilities Total2.8 B2.6 B745 M
Slightly volatile
Other Current Assets108.3 M60.1 M63.6 M
Slightly volatile
Other Stockholder Equity3.5 B3.4 B1.1 B
Slightly volatile
Total Liabilities2.9 B2.8 B852.5 M
Slightly volatile
Total Current Assets1.1 BB296.9 M
Slightly volatile
Short Term Debt30.5 M32.1 M32.3 M
Slightly volatile
Intangible Assets3.6 MM3.8 M
Slightly volatile
Common Stock3.3 K3.5 K7.2 K
Slightly volatile
Current Deferred Revenue15.5 M16.3 M39.9 M
Slightly volatile
Capital Lease Obligations132.2 M125.9 M39.4 M
Slightly volatile
Property Plant And Equipment Gross807.3 M1.2 B450.7 M
Slightly volatile
Short and Long Term Debt17.8 M18.7 M27.4 M
Slightly volatile
Capital Stock3.3 K3.5 K7.2 K
Slightly volatile
Non Current Liabilities Other16.7 M17.6 M71.4 M
Pretty Stable
Short Term Investments14.4 M27.5 MM
Slightly volatile

Core Scientific Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization145 M138.1 M47.9 M
Slightly volatile
Interest Expense49.3 M42.6 M23.5 M
Slightly volatile
Selling General Administrative95.4 M127 M57.1 M
Slightly volatile
Selling And Marketing Expenses12 M11.5 M5.2 M
Slightly volatile
Total Revenue424.9 M587.3 M253.9 M
Slightly volatile
Gross Profit93.8 M139.2 M55.9 M
Slightly volatile
Other Operating Expenses338.8 M609.3 M240.4 M
Slightly volatile
Research Development11.8 M13.6 M8.6 M
Slightly volatile
Cost Of Revenue331.1 M448 M198 M
Slightly volatile
Total Operating Expenses229.3 M161.3 M115.6 M
Slightly volatile
Reconciled Depreciation106.8 M138.1 M55 M
Slightly volatile

Core Scientific Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation62.1 M59.7 M31.5 M
Slightly volatile
Begin Period Cash Flow52.4 M80.2 M36.4 M
Slightly volatile
Depreciation90.1 M138.1 M52.3 M
Slightly volatile
Capital Expenditures148.7 M109.2 M86.1 M
Slightly volatile
End Period Cash FlowB962.5 M233.6 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.656.333.126
Slightly volatile
Days Sales Outstanding0.80.842.0599
Very volatile
Stock Based Compensation To Revenue0.0880.09150.0759
Slightly volatile
Capex To Depreciation0.860.914.0284
Slightly volatile
EV To Sales7.326.983.4578
Slightly volatile
Payables Turnover11.1918.210.1242
Slightly volatile
Sales General And Administrative To Revenue0.260.250.2524
Very volatile
Research And Ddevelopement To Revenue0.05010.02660.0693
Slightly volatile
Capex To Revenue0.350.210.4787
Slightly volatile
Cash Per Share3.092.940.6936
Slightly volatile
Days Payables Outstanding15.4316.2448.4992
Pretty Stable
Intangibles To Total Assets0.00340.00360.2694
Slightly volatile
Current Ratio6.356.051.6958
Slightly volatile
Receivables Turnover471448242
Slightly volatile
Capex Per Share0.620.430.7193
Slightly volatile
Revenue Per Share1.421.81.5439
Slightly volatile
Interest Debt Per Share4.574.351.3911
Slightly volatile
Debt To Assets0.340.680.2358
Slightly volatile
Graham Number4.625.195.6639
Slightly volatile
Operating Cycle0.80.842.0599
Very volatile
Days Of Payables Outstanding15.4316.2448.4992
Pretty Stable
Long Term Debt To Capitalization2.013.811.5506
Slightly volatile
Quick Ratio6.356.051.6958
Slightly volatile
Net Income Per E B T0.750.90.8027
Slightly volatile
Cash Ratio5.875.591.2808
Slightly volatile
Days Of Sales Outstanding0.80.842.0599
Very volatile
Fixed Asset Turnover0.650.690.7521
Pretty Stable
Debt Ratio0.340.680.2358
Slightly volatile
Price Sales Ratio6.656.333.126
Slightly volatile
Asset Turnover0.360.290.3901
Pretty Stable
Gross Profit Margin0.170.210.1905
Pretty Stable

Core Fundamental Market Drivers

Forward Price Earnings29.1545
Cash And Short Term Investments836.2 M

About Core Scientific Financial Statements

Core Scientific investors use historical fundamental indicators, such as Core Scientific's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Core Scientific. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue16.3 M15.5 M
Total Revenue587.3 M424.9 M
Cost Of Revenue448 M331.1 M
Stock Based Compensation To Revenue 0.09  0.09 
Sales General And Administrative To Revenue 0.25  0.26 
Research And Ddevelopement To Revenue 0.03  0.05 
Capex To Revenue 0.21  0.35 
Revenue Per Share 1.80  1.42 
Ebit Per Revenue(0.04)(0.05)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Core Stock Analysis

When running Core Scientific's price analysis, check to measure Core Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific is operating at the current time. Most of Core Scientific's value examination focuses on studying past and present price action to predict the probability of Core Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific's price. Additionally, you may evaluate how the addition of Core Scientific to your portfolios can decrease your overall portfolio volatility.